Effect of Probiotics on Serum Biochemical and Blood Constituents in Chicken Challenged with Salmonella enterica Subsp Typhimurium
Purpose: To examine the effects of two commercial probiotics (Toyocerin and CloSTAT) on serum enzyme activities, and hematological and biochemical indices of broiler chickens challenged with Salmonella enterica serovars Typhimurium (ST).
Methods: The chicks received one of the following treatments at 0 day of age: T1 = control group, unmedicated diet, unchallenged birds, (negative control); T2 = unmedicated diet + bacterial challenge (positive control); T3 = medicated diet with neoxyval (0.05 g/kg diet) + bacterial challenge (NEOX); T4 = toyocerin (1 g/kg diet) + bacterial challenge (Toyocerin); and T5 = CloSTAT (1 g/kg diet) + bacterial challenge (COLS). Blood samples were withdrawn from 7 selected chicks in each treatment at 7, 21, 28, 35 and 42 days of age, and analyzed for total protein, albumin and globulin concentration, and the albumin: globulin ratio computed. Glutamate-oxaloacetate transaminase (GOT) and glutatamate pyruvate transaminase (GPT) levels in serum were measured on days 7 and 42.
Results: The results revealed that albumin (p < 0.001), globulin (p < 0.001) and albumin: globulin ratio (p < 0.001) were influenced by the time of blood collection. Globulin increased significantly after ST challenge while albumin decreased significantly. Glutamate oxaloacetate transaminase (GOT) after ST challenge was affected by treatment (p < 0.05). Higher levels were obtained from birds which had received NEOX or positive control, compared to negative control group.
Conclusion: Salmonella challenge affects serum albumin, globulin and GOT enzyme. The results obtained suggest that the probiotic, Toyocerin, mitigates the negative effects of Salmonella challenge.
Keywords: Bacillus subtilis PB6, Bacillus Cereus var. toyoi, Probiotics, Liver enzymes, Hematology, Salmonella enterica
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.